title: Redox manipulation of DNA binding activity and BuGR epitope reactivity of the glucocorticoid receptor.
abstract: Treatment of the transformed glucocorticoid receptor with hydrogen peroxide promotes the formation of disulfide bonds and inhibits the ability of the receptor to bind to DNA (Tienrungroj, W., Meshinchi, S., Sanchez, E. R., Pratt, S. E., Grippo, J. F., Holmgren, A., and Pratt, W. B. (1987) J. Biol. Chem. 262, 6992-7000). It has not been determined whether the inhibition of DNA binding activity is due to disulfide bonds formed within the DNA binding domain or between the DNA binding domain and another region of the receptor. In this paper, we examined the ability of hydrogen peroxide to inactivate the DNA binding activity of the mouse glucocorticoid receptor. We show that inhibition of DNA binding activity caused by hydrogen peroxide can be accounted for entirely by the formation of disulfide bonds between cysteine residues lying within the 15-kDa tryptic fragment containing the DNA binding domain of the receptor. Reversal of the peroxide-induced inactivation of DNA binding activity requires both zinc and a thiol-disulfide exchange reagent, such as dithiothreitol. Peroxide also eliminates recognition of the intact receptor and the 15-kDa tryptic fragment by the BuGR monoclonal antibody, and the reactivity of the BuGR epitope is restored by reduction without a requirement for zinc. Pretreatment of the receptor with methyl methanethiosulfonate inhibits much of the peroxide-mediated inactivation of the BuGR epitope but pretreatment with N-ethylmaleimide does not. Similarly, DNA binding activity of the receptor is inhibited by methyl methanethiosulfonate but not by N-ethylmaleimide. These results are consistent with the proposal that peroxide promotes the formation of disulfide bonds between thiols that lie spatially close to one another in the 15-kDa tryptic fragment, resulting in rapid elimination of zinc. Restoration of the zinc finger structure restores DNA-binding activity but restoration of the BuGR epitope requires only reduction without restoration of the zinc fingers.
authors.affiliation: Department of Pharmacology, University of Michigan Medical School, Ann Arbor 48109-0626.
authors.forename: K A
authors.initials: KA
authors.lastname: Hutchison
authors.forename: G
authors.initials: G
authors.lastname: Matić
authors.forename: S
authors.initials: S
authors.lastname: Meshinchi
authors.forename: E H
authors.initials: EH
authors.lastname: Bresnick
authors.forename: W B
authors.initials: WB
authors.lastname: Pratt
mesh_terms: D000818:Animals; D015153:Blotting, Western; D002478:Cells, Cultured; D002918:Chymotrypsin / Q000737:chemistry; D004247:DNA / Q000037:antagonists & inhibitors / Q000187:drug effects / Q000378:metabolism*; D004229:Dithiothreitol / Q000737:chemistry; D004591:Electrophoresis, Polyacrylamide Gel; D000939:Epitopes / Q000276:immunology*; D006861:Hydrogen Peroxide / Q000494:pharmacology; D008623:Mercaptoethanol / Q000737:chemistry; D051379:Mice; D010084:Oxidation-Reduction; D011965:Receptors, Glucocorticoid / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism; D014357:Trypsin / Q000737:chemistry; D015032:Zinc / Q000737:chemistry
chemical_list: D000939:Epitopes; D011965:Receptors, Glucocorticoid; D008623:Mercaptoethanol; D004247:DNA; D006861:Hydrogen Peroxide; D002918:Chymotrypsin; D014357:Trypsin; D015032:Zinc; D004229:Dithiothreitol